These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30898021)

  • 21. Methods for generating multivalent and bispecific antibody fragments.
    Tomlinson I; Holliger P
    Methods Enzymol; 2000; 326():461-79. PubMed ID: 11036658
    [No Abstract]   [Full Text] [Related]  

  • 22. Purification of antibody heteropolymers using hydrophobic interaction chromatography.
    Kostareva I; Hung F; Campbell C
    J Chromatogr A; 2008 Jan; 1177(2):254-64. PubMed ID: 17981289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current strategies in antibody engineering: Fc engineering and pH-dependent antigen binding, bispecific antibodies and antibody drug conjugates.
    Vincent KJ; Zurini M
    Biotechnol J; 2012 Dec; 7(12):1444-50. PubMed ID: 23125076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling of bispecific antibody elution in mixed-mode cation-exchange chromatography.
    Lee YF; Kluters S; Hillmann M; von Hirschheydt T; Frech C
    J Sep Sci; 2017 Sep; 40(18):3632-3645. PubMed ID: 28714211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification of hydrophobic complex antibody formats using a moderately hydrophobic mixed mode cation exchange resin.
    Koehnlein W; Holzgreve A; Schwendner K; Skudas R; Schelter F
    J Chromatogr A; 2023 Jan; 1687():463696. PubMed ID: 36508767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of bispecific antibodies: diabodies and tandem scFv.
    Hornig N; Färber-Schwarz A
    Methods Mol Biol; 2012; 907():713-27. PubMed ID: 22907382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering Bifunctional Antibodies with Constant Region Fusion Architectures.
    Du J; Cao Y; Liu Y; Wang Y; Zhang Y; Fu G; Zhang Y; Lu L; Luo X; Kim CH; Schultz PG; Wang F
    J Am Chem Soc; 2017 Dec; 139(51):18607-18615. PubMed ID: 29186655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications.
    Byrne H; Conroy PJ; Whisstock JC; O'Kennedy RJ
    Trends Biotechnol; 2013 Nov; 31(11):621-32. PubMed ID: 24094861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of viruses using novel protein A wash buffers.
    Bolton GR; Selvitelli KR; Iliescu I; Cecchini DJ
    Biotechnol Prog; 2015; 31(2):406-13. PubMed ID: 25482293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential affinity purification of peroxidase tagged bispecific anti-SARS-CoV antibodies on phenylboronic acid agarose.
    Bhatnagar PK; Das D; Suresh MR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Mar; 863(2):235-41. PubMed ID: 18258500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Affinity chromatography and co-chromatography of bispecific monoclonal antibody immunoconjugates.
    Gupta S; Suresh M
    J Biochem Biophys Methods; 2002 May; 51(3):203-16. PubMed ID: 12088881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair.
    Strop P; Ho WH; Boustany LM; Abdiche YN; Lindquist KC; Farias SE; Rickert M; Appah CT; Pascua E; Radcliffe T; Sutton J; Chaparro-Riggers J; Chen W; Casas MG; Chin SM; Wong OK; Liu SH; Vergara G; Shelton D; Rajpal A; Pons J
    J Mol Biol; 2012 Jul; 420(3):204-19. PubMed ID: 22543237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development.
    Ollier R; Wassmann P; Monney T; Ries Fecourt C; Gn S; C A V; Ayoub D; Stutz C; Gudi GS; Blein S
    MAbs; 2019; 11(8):1464-1478. PubMed ID: 31462177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient generation of bispecific IgG antibodies by split intein mediated protein trans-splicing system.
    Han L; Chen J; Ding K; Zong H; Xie Y; Jiang H; Zhang B; Lu H; Yin W; Gilly J; Zhu J
    Sci Rep; 2017 Aug; 7(1):8360. PubMed ID: 28827777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alkaline cation-exchange chromatography for the reduction of aggregate and a mis-formed disulfide variant in a bispecific antibody purification process.
    Hall T; Wilson JJ; Brownlee TJ; Swartling JR; Langan SE; Lambooy PK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 975():1-8. PubMed ID: 25462105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COMBODY: one-domain antibody multimer with improved avidity.
    Zhu X; Wang L; Liu R; Flutter B; Li S; Ding J; Tao H; Liu C; Sun M; Gao B
    Immunol Cell Biol; 2010 Aug; 88(6):667-75. PubMed ID: 20212511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of chimeric bispecific G250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinoma.
    Luiten RM; Coney LR; Fleuren GJ; Warnaar SO; Litvinov SV
    Br J Cancer; 1996 Sep; 74(5):735-44. PubMed ID: 8795576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of new affinity chromatography resins for polyclonal, oligoclonal and monoclonal antibody pharmaceuticals.
    Ishihara T; Nakajima N; Kadoya T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(23):2141-4. PubMed ID: 20591751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of recent Protein A stationary phase innovations for capture of biotherapeutics.
    Pabst TM; Thai J; Hunter AK
    J Chromatogr A; 2018 Jun; 1554():45-60. PubMed ID: 29685337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guiding bispecific monovalent antibody formation through proteolysis of IgG1 single-chain.
    Dimasi N; Fleming R; Sachsenmeier KF; Bezabeh B; Hay C; Wu J; Sult E; Rajan S; Zhuang L; Cariuk P; Buchanan A; Bowen MA; Wu H; Gao C
    MAbs; 2017 Apr; 9(3):438-454. PubMed ID: 28055299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.